Inavolisib CAS 2060571-02-8 Highly Selective PI3Kα Inhibitor for Breast Cancer Research High Purity Reference Standard kr
TDS
2060571-02-8
Reagent Grade
99%
qingdao
//
5g, 25g, 100g, 500g
2026-10-01
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceGDC-0077 is under investigation in clinical trial NCT03006172 (To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer).|Inavolisib is an orally available inhibitor of phosphatidylinositol 3-kinase (PI3K), with potential antineoplastic activity. inavolisib binds to and inhibits various members of the PI3K family, including activating mutations in the catalytic alpha isoform PIK3CA. PI3K inhibition prevents the activation of the PI3K-mediated signaling pathway and results in the inhibition of growth and survival of PI3K-overexpressing tumor cells. Dysregulation of the PI3K signaling pathway is frequently associated with tumorigenesis and tumor resistance to a variety of antineoplastic agents and radiotherapy. PIK3CA, which encodes the p110-alpha catalytic subunit of the class I PI3K, is frequently mutated in a variety of cancer cell types and plays a key role in cancer cell growth and invasion.Certificates
-
TDS
Basic Info-
Product Name:
Inavolisib
Other Name:GDC-0077;2060571-02-8;Inavolisib;RG6114;GDC0077;UNII-L4C1UY2NYH;L4C1UY2NYH;Ro7113755;(S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide;(2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
CAS No.:2060571-02-8
Molecular Formula:C18H19F2N5O4
InChIKeys:SGEUNORSOZVTOL-CABZTGNLSA-N
Exact Mass:407.14051043
UNII:L4C1UY2NYH
NCI Thesaurus Code:C132166
Categories:
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Location:
RONGSHENG BEIYUANDAJIE 9, LICHENG DISTRICT,JINAN, SHANDONG CHINA
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
- Hot Searches
- where to buy tianeptine
- prednisolone vs prednisolone sodium phosphate
- meerwein's salt
- what's the price of kerosene
- anhydrous ammonia suppliers near me
- is miconazole nitrate the same as miconazole
- carbon tetrabromide
- where to buy enclomiphene citrate
- ethylene vinyl acetate price
- buy nandrolone
- acetone chemical compound
- where to buy anhydrous ammonia